Learning from our failures in blood-brain permeability: What can be done for new drug discovery?

Expert Opinion on Drug Discovery

Volumn 10, Issue 3, 2015, Pages 207-211

  Martel, Sylvain ^a  

^a ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

Author keywords

Blood brain barrier; Carrier mediated transport; Hyperthermia; Nanotechnology; Navigable agents; Receptor mediated transport

Indexed keywords

NEW DRUG; PRODRUG; DRUG;

ACTIVE TRANSPORT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD BRAIN PERMEABILITY; BRAIN CAPILLARY; BRAIN TISSUE; DRUG DELIVERY SYSTEM; DRUG RESEARCH; EXTRACELLULAR FLUID; HUMAN; HYPERTHERMIA; NANOTECHNOLOGY; PERMEABILITY; PERMEABILITY BARRIER; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; THERAPY EFFECT; TRANSCYTOSIS; ANIMAL; BRAIN; BRAIN DISEASES; DRUG DESIGN; DRUG DEVELOPMENT; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; BRAIN DISEASES; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG DISCOVERY; HUMANS; PERMEABILITY; PHARMACEUTICAL PREPARATIONS;

EID: 84923339161     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2015.1009443     Document Type: Article

References (8)

1. Fung LK, Shin M, Tyler B, et al. Chemotherapeutic drug released from polymers: distribution of 1,3-bis (2-chloroethyl)-1-nitrosourea in the rat brain. Pharm Res 1996;13(5):671-82
2. Salvatore MF, Ai Y, Fischer B, et al. Point source concentration of GDNF may explain failure of phase II clinical trial. Exp Neurol 2006;202(2):497-505
3. Wu H, Hu K, Jiang X. From node to brain: understanding transport capacity and transport rate of drugs. Expert Opin Drug Deliv 2008;5(10):1159-68
4. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005;2(1):3-14 • Provide a good overview of the difficulties imposed by the BBB.
5. Pardridge WM. Drug transport across the blood-brain barrier. J Cerebral Blood Flow & Metabolism 2012;32(11):1959-72 • Provide a more recent overview of the difficulties imposed by the BBB.
6. Mesiwala AH, Farrell L, Wenzel HJ, et al. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med Biol 2002;28(3):389-400
7. Jain KK. Nanobiotechnology-based strategies for crossing the blood-brain barrier. Nanomedicine 2012;7(8):1225-33
8. Martel S. Magnetic therapeutic delivery using navigable agents. Therapeutic Delivery 2014;5(2):189-204 •• For a recent review of nano-robotically assisted methods that could prove beneficial for drug discovery to the brain.